NRx Pharmaceuticals, Inc. (NRXP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 7.36M | 8.89M | 11.95M | 4.59M | 7.26M | 3.3M | 4.11M | 4.88M | 3.35M | 6.88M | 13.09M | 19.79M |
| Cash & Short-Term Investments | 6.71M | 7.8M | 7.18M | 2.91M | 5.55M | 1.44M | 1.65M | 1.9M | 1.32M | 4.59M | 8.9M | 14.97M |
| Cash Only | 6.71M | 7.8M | 7.18M | 2.91M | 5.55M | 1.44M | 1.65M | 1.9M | 1.32M | 4.59M | 8.9M | 14.97M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 181K | 161K | 239K | 0 | 0 | 0 | 6K | 6K | 6K | 6K | 6K | 6K |
| Days Sales Outstanding | 14.41 | 18.72 | 90.86 | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 4.52M | 0 | 0 | 0 | 0 | 0 | 128K | 0 | 0 | 0 |
| Total Non-Current Assets | 4.54M | 4.06M | 3.05M | 248K | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K |
| Property, Plant & Equipment | 936K | 696K | 350K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | 1.31x | 1.88x | 0.69x | - | - | - | - | - | - | - | - | - |
| Goodwill | 1.79M | 1.79M | 610K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 879K | 925K | 1.78M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 399K | 397K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 535K | 253K | 312K | 248K | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K |
| Total Assets | 11.9M | 12.96M | 15M | 4.84M | 7.59M | 3.65M | 4.46M | 5.26M | 3.79M | 7.32M | 13.11M | 19.81M |
| Asset Turnover | 0.09x | 0.07x | 0.02x | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 56.82% | 254.86% | 236.08% | -8.09% | 100.37% | -50.09% | -65.96% | -73.43% | -82.61% | -71.66% | -47.19% | -38.92% |
| Total Current Liabilities | 25.18M | 28.58M | 40.59M | 40.45M | 32.75M | 21.86M | 20.3M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M |
| Accounts Payable | 4.4M | 4.27M | 4.26M | 3.63M | 4.31M | 4.13M | 4.87M | 5.01M | 6.26M | 4.63M | 3.63M | 2.21M |
| Days Payables Outstanding | 490.08 | 772.13 | 2.63K | - | - | 413.82K | 227.26K | 513.24K | 495.81K | 380.1K | 134.23K | 272.14K |
| Short-Term Debt | 391K | 316K | 189K | 10.23M | 8.4M | 1.57M | 3.68M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 20.39M | 23.5M | 36.15M | 21.42M | 15.12M | 10.93M | 11.35M | 9.6M | 26K | 4.42M | 10K | 36K |
| Current Ratio | 0.29x | 0.31x | 0.29x | 0.11x | 0.22x | 0.15x | 0.20x | 0.21x | 0.18x | 0.36x | 0.68x | 0.87x |
| Quick Ratio | 0.29x | 0.31x | 0.29x | 0.11x | 0.22x | 0.15x | 0.20x | 0.21x | 0.18x | 0.36x | 0.68x | 0.87x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 543K | 315K | 158K | 0 | 0 | 5.01M | 2.98M | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 543K | 0 | 158K | 0 | 0 | 5.01M | 2.98M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 315K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 25.72M | 28.89M | 40.75M | 40.45M | 32.75M | 26.87M | 23.28M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M |
| Total Debt | 934K | 631K | 347K | 10.23M | 8.4M | 6.58M | 6.67M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M |
| Net Debt | -5.78M | -7.17M | -6.84M | 7.32M | 2.85M | 5.13M | 5.02M | 6.7M | 5.46M | 4.57M | 1.17M | -2.28M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -20.38x | -6.85x | - | - | - | - | - | -8.30x | -27.38x | -53.15x | -150.55x | - |
| Total Equity | -13.82M | -15.94M | -25.75M | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M | -15.07M | -11.73M | -6.22M | -2.81M |
| Equity Growth % | 45.09% | 31.37% | -36.83% | -93.65% | -66.97% | -97.93% | -202.75% | -554.95% | -5205.99% | -258.36% | -137.05% | -111.08% |
| Book Value per Share | -0.43 | -0.50 | -1.16 | -1.99 | -1.53 | -2.21 | -1.72 | -1.75 | -1.70 | -0.14 | -0.76 | -0.04 |
| Total Shareholders' Equity | -13.82M | -15.94M | -25.75M | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M | -15.07M | -11.73M | -6.22M | -2.81M |
| Common Stock | 33K | 32K | 28K | 19K | 17K | 15K | 11K | 11K | 10K | 84K | 84K | 80K |
| Retained Earnings | -308.32M | -306.89M | -307.26M | -301.37M | -283.79M | -278.27M | -269.19M | -267.57M | -259.68M | -253.15M | -248.81M | -242.75M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3K | -3K | -3K | -22K | -22K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |